This inventor holds 4 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignee: Intellia Therapeutics, Inc.. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: Amy Madison Rhoden Smith: Innovator in Gene Editing
Introduction
Amy Madison Rhoden Smith is a prominent inventor based in Durham, NC (US). She has made significant contributions to the field of gene editing, holding a total of three patents. Her work focuses on improving the efficiency and effectiveness of gene editing methods.
Latest Patents
Among her latest patents is a disclosure on modified guide RNAs. This innovation relates to modified single and dual guide RNAs that exhibit improved in vitro and in vivo activity in gene editing methods. Another notable patent involves polynucleotides, compositions, and methods for genome editing. This patent provides compositions and methods that include a polynucleotide encoding Cas9, which can enhance editing efficiency and reduce immunogenicity.
Career Highlights
Amy is currently employed at Intellia Therapeutics, Inc., where she continues to advance her research in gene editing technologies. Her work is pivotal in the development of new therapeutic approaches that leverage gene editing for medical applications.
Collaborations
She collaborates with esteemed colleagues, including David Morrissey and Walter R Strapps, who contribute to her innovative projects and research endeavors.
Conclusion
Amy Madison Rhoden Smith is a trailblazer in the field of gene editing, with her patents reflecting her commitment to advancing scientific knowledge and technology. Her contributions are shaping the future of genetic research and therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile